Full Text DK-97-001
NIH GUIDE, Volume 26, Number 14, May 2, 1997
RFA:  DK-97-001
P.T. 04

  Biomedical Research, Multidiscipl 

National Institute of Diabetes and Digestive and Kidney
Letter of Intent Receipt Date: August 25, 1997
Application Receipt Date:  September 24, 1997
This Request for Applications (RFA) invites investigators to submit
research grant applications for the George M. O'Brien Research
Centers Program.  The emphases for this program are to: (1) attract
new scientific expertise into the study of the basic mechanisms of
kidney diseases and disorders; and (2) encourage multidisciplinary
research focused on the causes of these diseases.  In approaching the
study of these disease processes, it is anticipated that extensive
collaboration will be required between individuals in the clinical
and basic sciences, including for example investigators with training
and expertise in cell biology, molecular biology, immunology,
genetics, epidemiology, biochemistry, physiology, and pathology. It
is the express intent of this RFA to attract new investigators not
currently active in this field and to explore new basic areas that
may have clinical research applications.  Individual institutions
with both basic and clinical research capabilities are eligible to
apply.  Inter-institutional collaborative research arrangements are
also appropriate and encouraged. Coordination for such arrangements
must be evident and clearly meaningful and appropriate for the
research proposed.
The Public Health Service (PHS) is committed to achieving the health
promotion and disease prevention objectives of "Healthy People 2000,"
a PHS-led national activity for setting priority areas.  This RFA,
Kidney Research Centers, is related to the priority area of chronic
debilitating diseases.  Potential applicants may obtain a copy of
"Healthy People 2000" (Full Report:  Stock No. 017-001-00474-0 or
Summary Report:  Stock No. 017-001-00473-1) through the
Superintendent of Documents, Government Printing Office, Washington,
DC 20402-9325 (telephone: 202/512-1800).
Applications may be submitted by domestic for-profit and non-profit
organizations, public and private, such as universities, colleges,
hospitals, laboratories, units of State and local governments, and
eligible agencies of the Federal government.  Racial/ethnic minority
individuals, women, and persons with disabilities are encouraged to
apply as Principal Investigators.  Foreign institutions are not
eligible to apply.
Support of this program will be through the NIH specialized center
(P50) award.  Responsibility for the planning, direction, and
execution of the proposed project will be solely that of the
applicant.  Awards will be administered under PHS grants policy as
stated in the PHS Grants Policy Statement.  This RFA is a one-time
solicitation.  The total requested project period for applications
submitted in response to this RFA may not exceed five years.
Applicants from institutions that have a General Clinical Research
Center (GCRC) funded by the NIH National Center for Research
Resources may wish to identify the GCRC as a resource for conducting
the proposed research.  If so, a letter of agreement  from either the
GCRC program director or principal investigator should be included
with the application.
The National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK) expects to award up to three center grants (P50) for research
into kidney disorders in fiscal year 1998. The anticipated awards are
for five years and are contingent upon the availability of
appropriated funds.  The total amount of available funds to support
this program is anticipated to be no more than $2.15 million per
year.  No applicant may request more than $750,000 in total costs
(including both direct and indirect costs) in the initial budget
period.  A standard escalation factor may be used for subsequent
budget periods.
Two competing continuation applications are anticipated in response
to this RFA.  The budget for the first year of a competing
continuation application may be increased by 10% above the direct
cost budget of the last issued noncompetitive (Type 5) award.  In all
cases, budgets are not to exceed the $750,000 total cost cap.
Kidney diseases and disorders place a substantial burden on
individuals and on society in the United States.  They threaten the
health, well-being, and longevity of millions of Americans.  Chronic
renal failure, for example, accounted for an estimated $3.7 billion
of direct hospital and physician costs in 1990.  Although
considerable progress has been made in understanding the basic
physiology and pathophysiology of the normal renal systems, there has
been only limited progress in unraveling the mechanisms of those
processes that lead to progressive deterioration in the function of
these systems.  Nevertheless, major progress has been made in the
management of their clinical consequences.  For example, renal
dialysis and transplantation are life saving procedures.
Unfortunately, these scientific and medical advances have not led to
the means to prevent or reverse the consequences of these diseases
and disorders; moreover,  their incidence is steadily increasing.
The proposed multidisciplinary research centers should help to
provide an environment for investigators to apply the necessary and
appropriate expertise to topical areas of research, related to the
pathogenesis of kidney diseases such as: immunologically mediated
diseases, diabetes mellitus and other endocrine and metabolic
disorders, primary renal hypertension, genetic abnormalities, and
nephrotoxins and toxic cell injury.
Successful applicants are expected to attend a yearly meeting of
Center Directors convened by the NIDDK.  Funds to support travel to
this meeting may be requested in the budget proposed for the center.
It is the policy of the NIH that women and members of minority groups
and their sub-populations must be included in all NIH supported
biomedical and behavioral research projects involving human subjects,
unless a clear and compelling rationale and justification is provided
that inclusion is inappropriate with respect to the health of the
subjects or the purpose of the research.  This policy results from
the NIH Revitalization Act of 1993 (Section 492B of Public Law
103-43).  All investigators proposing research involving human
subjects should read the "NIH Guidelines For Inclusion of Women and
Minorities as Subjects in Clinical Research," which have been
published in the Federal Register of March 20, 1994 (FR 59
14508-14513), and in the NIH Guide for Grants and Contracts  Vol. 23,
No. 11, March 18, 1994.
Prospective applicants are asked to submit, by August 25, 1997, a
letter of intent that includes a descriptive title of the proposed
research; the name, address, and telephone number of the Principal
Investigator; the identities of other key personnel and participating
institutions; and the number and title of the RFA in response to
which the application may be submitted.
Although a letter of intent is not required, is not binding, and does
not enter into the review of a subsequent application,  the
information that it contains allows NIDDK staff to estimate  the
potential review workload and avoid conflict of interest in the
The letter of intent is to be sent to:
Chief, Review Branch
Division of Extramural Activities
National Institute of Diabetes and Digestive and Kidney Diseases
45 Center Drive, Room 6AS-37F - MSC 6600
Bethesda, MD  20892-6600
Telephone:  (301) 594-8885
FAX:  (301) 480-3505
The research grant application form PHS 398 (rev. 5/95) is to be used
in applying for these grants.  Applications kits are available at
most institutional offices of sponsored research and may be obtained
from the Division of Extramural Outreach and Information Resources,
National Institutes of Health, 6701 Rockledge Drive, MSC 7910,
Bethesda, MD 20892-7910, telephone 301/710-0267, email:
Applications must include the following items:
Applicants are to follow the NIDDK Program Project Grants Guidelines
(July 1996) for preparation of the Grant Application, Chapter 3.
Copies of the Guidelines are available from the Program Director
listed under INQUIRIES.
Each Research Project proposed (Section F -  NIDDK Guidelines)  is
limited to 25 pages of text.
Applications should contain the following:
o  A Table of Contents
o  A Rationale for the Proposed Center and a Statement of Objectives.
o  Institutional Environment and Resources.
o  Organization and Administrative Structure of the Center.
o  Specific Managerial Responsibilities for the Center.
o  Travel funds in the proposed budget for an annual meeting of
Center Directors.
o  A description of the method for the replacement of the Center
Director (should the need arise).
o  A description of the proposed research projects.
o  A description of the proposed cores.
o  A description of the procedure to be used for the
addition/deletion of cores and projects during the proposed period of
o  A description of the administrative relationship of the Center to
the applicant institution.
The RFA label available in the PHS 398 (rev. 5/95) application form
must be affixed to the bottom of the face page of the application.
Failure to use this label could result in delayed processing of the
application such that it may not reach the review committee in time
for review.  In addition, the RFA title and number must be typed on
line 2 of the face page of the application form and the YES box must
be marked.
Submit a signed, typewritten original of the application, including
the Checklist, plus three signed photocopies, in one package to:
6701 ROCKLEDGE DRIVE, ROOM 1040 - MSC 7710
BETHESDA, MD 20892-7710
BETHESDA, MD 20817 (For Express/Courier service)
At time of submission, two additional copies of the application must
be sent to:
Chief, Review Branch
Division of Extramural Activities
National Institute of Diabetes and Digestive and Kidney Diseases
45 Center Drive, Room 6AS-37F - MSC 6600
BETHESDA, MD 20892-6600
Applications must be received by September 24, 1997.  If an
application is received after that date, it will be returned to the
applicant without review.
Upon receipt, applications will be initially reviewed for
completeness and responsiveness.  Incomplete applications and/or
non-responsive applications will be returned to the applicant without
further consideration.  Evaluation for responsiveness to the program
requirements and criteria stated in the RFA is an NIDDK staff
function. Unsolicited material received after September 24, 1997 will
not be accepted.
Applications that are complete and responsive to the RFA will be
evaluated for scientific and technical merit by an appropriate peer
review group convened by the NIDDK in accordance with NIH peer review
procedures.  As part of the initial merit review, all applications
will receive a written critique and undergo a process in which only
those applications deemed to have the highest scientific merit will
be discussed, assigned a priority score, and receive a second level
review by the National Diabetes and Digestive and Kidney Advisory
The review criteria for individual research projects include:
o  The scientific, technical or medical significance and originality
of the proposed research.
o  The feasibility and adequacy of the experimental design;
o  The qualifications and research experience of the proposed
o  The availability of resources necessary for the research;
o  The appropriateness of the budget and timetable in relation to the
scope of the proposed research.
o  Adequacy of plans to include both genders and minorities and their
subgroups as appropriate for the scientific goals of the research.
Plans for the recruitment and retention of subjects will also be
The review criteria for scientific cores include:
o  The appropriateness and utility of the core to the proposed
o  The quality of the proposed facilities or services including
administrative arrangements for utilizing the core.
o  The qualifications, experience, and commitment of the personnel
involved in the core.
o  The appropriateness of the budget.
Note: Each core unit must provide facilities or services to at least
two research projects recommended for approval;
The review criteria for the overall Center program include:
o  The scientific merit of the program as a whole.
o  The significance of the overall goals of the Center.
o  The cohesiveness and multidisciplinary scope of the Center and the
coordination and interrelationship of the projects and cores to the
common theme of the Center;
o  The leadership, scientific expertise, and commitment of the
proposed Center Director.
Administrative considerations include:
o  The institutional environment for and resources available to
Center investigators.
o  The institutional commitment to the proposed Center.
o  The administrative leadership necessary to provide for the quality
control of supported projects in the Center, the allocation of funds,
and the ability to foster communication and cooperation among Center
o  The appropriateness of the budget in relation to the proposed
activities of the Center.
o  The adequacy of addressing the protection of human subjects,
animal welfare, and biohazard issues.
Competing Continuation Applications
Applicants are to follow the NIDDK Program Project Grants Guidelines
(July 1996) for preparation of the Grant Application, Chapter 4, Part
B and Part C.  Copies of the Guidelines are available from the
Program Director listed under INQUIRIES.
For the purposes of this RFA a distinction between a P50 grant and a
P01 grant is made as follows:
Research projects supported by the P50 center award are of uniformly
high scientific merit, and are generally related to central issues in
kidney diseases and disorders.  Each project should be directed to
the development of fundamental knowledge leading to understanding
disease processes and the design of curative or preventative
strategies.  The P50 grant mechanism provides an opportunity to
approach multi- disciplinary basic research in a synergistic fashion.
Close cooperation, communication, and collaboration among all center
personnel of many professional disciplines are characteristics of a
successful P50 center.
In comparison, each research project of the P01 Program Project Grant
must contribute to or be directly related to a clearly defined
central unifying theme of the total research effort.  The projects
should demonstrate essential elements of unity and interdependence.
Letter of Intent Receipt Date:  August 25, 1997
Application Receipt Date:       September 24, 1997
Initial Review:                 February/April 1998
Second Level Review:            May 1998
Anticipated Date of Award:      September 1, 1998
The earliest anticipated date of award is September 1, 1998.  Factors
that will be taken into consideration in making awards include the
scientific merit of the proposed Center as determined by peer review
and the availability of funds.
Inquiries concerning this RFA are encouraged.  The opportunity to
clarify any issues or questions from potential applicants is welcome.
Direct inquiries regarding programmatic issues to:
Ralph L. Bain, Ph.D.
Division of Kidney, Urologic, and Hematologic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
45 Center Drive, Room 6AS-19 - MSC 6600
Bethesda, MD  20892-6600
Telephone:  (301) 594-7717
FAX:  (301) 480-3510
Email:  bainr@ep.niddk.nih.gov
Direct inquiries regarding fiscal and administrative matters to:
Ms. Helen Ling
Division of Extramural Activities
National Institute of Diabetes and Digestive and Kidney Diseases
45 Center Drive, Room 6AN-44F - MSC 6600
Bethesda, MD  20892-6600
Telephone:  (301) 594-8857
FAX:  (301) 480-3504
Email:  lingh@ep.niddk.nih.gov
This program is described in the Catalog of Federal Domestic
Assistance No. 93.849.  Awards are made under authorization of the
Public Health Service Act, Title IV, Part A (Public Law 78-410, as
amended by Public Law 99-158, 42 USC 241 and 285) and administered
under PHS grants policies and Federal Regulations 42 CFR 52 and 45
CFR Part 74.  This program is not subject to the intergovernmental
review requirements of Executive Order 12372 or Health Systems Agency
The PHS strongly encourages all grant and contract recipients to
provide a smoke-free workplace and promote the non-use of all tobacco
products.  In addition, Public Law 103-227, the Pro-Children Act of
1994, prohibits smoking in certain facilities (or in some cases, any
portion of a facility) in which regular or routine education,
library, day care, health care or early childhood development
services are provided to children. This is consistent with the PHS
mission to protect and advance the physical and mental health of the
American people.

Return to RFAs Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.